drugset / Trial / NCT05764733
Bone, Exercise, Alendronate, and Caloric Restriction
Phase 4
Recruiting
900 enrolled
Wake Forest University Health Sciences
National Institute on Aging (NIA) · collab
RandomizedFactorialQuadruple-blindPrevention
Summary
The purpose of this research is to identify strategies that minimize bone loss that occurs when older adults lose weight. Participation in this research will involve up to nine assessment visits and last up to two years.
Timeline
- Start
- 2023-06-08
- Primary completion
- 2028-01
- Completion
- 2028-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Alendronic Acid | Small molecule | 70 mg | — |